Late results in re-treatment of patients with pulmonary tuberculosis.
D003523:Cycloserine / Q000009:adverse effects / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005000:Ethionamide / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D011718:Pyrazinamide / Q000009:adverse effects / Q000627:therapeutic use*; D013183:Sputum / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology / Q000401:mortality
D011718:Pyrazinamide; D003523:Cycloserine; D005000:Ethionamide